Effects of Acute Caffeine Ingestion on Morning Strength, Power and Repeated Sprint Measures in Males: A Standardized Approach

Vickery, SJ ORCID: 0009-0009-0707-6001, Giacomoni, M, Agulhari, JPS ORCID: 0009-0001-6225-3471, Batten, T, Crozier, OG ORCID: 0009-0007-3328-4790, Goorwappa, D, Mauvieux, B ORCID: 0000-0003-4862-6531, Pullinger, SA ORCID: 0000-0001-7680-3991, Chester, N ORCID: 0000-0001-8791-5040, Hesketh, SJ and Edwards, BJ ORCID: 0000-0001-8913-0941 (2026) Effects of Acute Caffeine Ingestion on Morning Strength, Power and Repeated Sprint Measures in Males: A Standardized Approach. Nutrients, 18 (15). ISSN 2072-6643

Preview

Text Effects of Acute Caffeine Ingestion on Morning Strength, Power and Repeated Sprint Measures in Males- A Standardized Approach.pdf - Published Version Available under License Creative Commons Attribution. Download (941kB) | Preview

Abstract

Background/Objectives: Repeated sprint performance is typically reduced during the morning because of circadian-related changes in physiological function and muscle strength. Acute caffeine supplementation may attenuate these decrements; however, evidence remains inconsistent. This is partly because of inadequate control of chronobiological and methodological confounders. This study investigated the effects of acute morning caffeine ingestion on repeated sprint performance, physiological responses, strength, power and mood under rigorously standardized chronobiological conditions. Methods: Seventeen recreationally active, low habitual caffeine-consumer males completed six laboratory visits comprising three familiarization sessions and three experimental trials in a performance grouped, randomized for starting condition, counterbalanced, double-blind, placebo-controlled, crossover design. Participants ingested either caffeine (CAFF; 300 mg, 2.5–5.3 mg·kg⁻¹), placebo (PLAC) or no-pill control (NoPill) 60 min before testing (07:30 h). Experimental sessions included assessments of mood, caffeine withdrawal symptoms, intra-aural temperature, grip strength, squat jump, countermovement jump and a 10 × 20 m repeated sprint protocol. Heart rate, ratings of perceived exertion (RPE), thermal comfort, blood lactate and blood glucose were assessed throughout the protocol. Data were analyzed using repeated-measures general linear models. Results: Caffeine did not significantly improve repeated sprint performance compared with PLAC or NoPill, although a trend towards faster 20 m sprint times was observed (3.39 ± 0.19 s vs. 3.43 ± 0.18 s and 3.41 ± 0.19 s, respectively; p = 0.070). Caffeine significantly reduced RPE (p = 0.029) but did not alter heart rate, blood lactate, blood glucose, thermal comfort, intra-aural temperature, mood, sleepiness, caffeine withdrawal symptoms nor lower-body power outcomes. Conclusions: Acute morning ingestion of 300 mg caffeine reduced perceived exertion but did not produce a clear ergogenic effect on repeated sprint performance under rigorously standardized chronobiological conditions. These findings suggest that, in low habitual caffeine users, the central perceptual effects of caffeine are insufficient to overcome the physiological constraints limiting morning repeated sprint performance and highlight the importance of rigorous chronobiological standardization when evaluating nutritional ergogenic aids.

Item Type:	Article
Uncontrolled Keywords:	placebo effect; RSA; RPE; diurnal variation; core temperature; Humans; Lactic Acid; Caffeine; Blood Glucose; Cross-Over Studies; Double-Blind Method; Affect; Circadian Rhythm; Heart Rate; Running; Adult; Male; Muscle Strength; Athletic Performance; Young Adult; RPE; RSA; core temperature; diurnal variation; placebo effect; Humans; Caffeine; Male; Double-Blind Method; Cross-Over Studies; Muscle Strength; Athletic Performance; Young Adult; Adult; Circadian Rhythm; Affect; Blood Glucose; Running; Heart Rate; Lactic Acid; 3214 Pharmacology and Pharmaceutical Sciences; 32 Biomedical and Clinical Sciences; 42 Health Sciences; Clinical Trials and Supportive Activities; Cardiovascular; Nutrition; Clinical Research; 6.1 Pharmaceuticals; Humans; Caffeine; Male; Double-Blind Method; Cross-Over Studies; Muscle Strength; Athletic Performance; Young Adult; Adult; Circadian Rhythm; Affect; Blood Glucose; Running; Heart Rate; Lactic Acid; 0908 Food Sciences; 1111 Nutrition and Dietetics; 3202 Clinical sciences; 3210 Nutrition and dietetics; 4206 Public health
Subjects:	R Medicine > RC Internal medicine > RC1200 Sports Medicine
Divisions:	Sport and Exercise Sciences
Publisher:	MDPI AG
Date of acceptance:	22 July 2026
Date of first compliant Open Access:	2 September 2026
Date Deposited:	02 Sep 2026 08:22
Last Modified:	02 Sep 2026 08:22
DOI or ID number:	10.3390/nu18152541
URI:	https://researchonline.ljmu.ac.uk/id/eprint/29271

View Item